These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9750468)

  • 1. [Detection of myeloma cells in the peripheral blood using flow cytometry].
    Adam Z; Klabusay M; Vorlícek J; Hájek R
    Vnitr Lek; 1997 Sep; 43(9):592-8. PubMed ID: 9750468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Detection of myeloma cells in peripheral blood using multi-parameter flow cytometry: monitoring residual disease].
    Klabusay M; Doubek M; Adam Z; Hájek R; Krivanová A
    Cas Lek Cesk; 2000 Jul; 139(14):432-6. PubMed ID: 11048405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
    Kara IO; Sahin B; Paydas S; Cetiner S
    Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of myeloma cells in the peripheral blood by flow cytometry.
    Witzig TE; Kimlinger TK; Ahmann GJ; Katzmann JA; Greipp PR
    Cytometry; 1996 Jun; 26(2):113-20. PubMed ID: 8817086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparameter analyses of normal and malignant human plasma cells: CD38++, CD56+, CD54+, cIg+ is the common phenotype of myeloma cells.
    Leo R; Boeker M; Peest D; Hein R; Bartl R; Gessner JE; Selbach J; Wacker G; Deicher H
    Ann Hematol; 1992 Mar; 64(3):132-9. PubMed ID: 1373957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two subsets of peripheral blood plasma cells defined by differential expression of CD45 antigen.
    Schneider U; van Lessen A; Huhn D; Serke S
    Br J Haematol; 1997 Apr; 97(1):56-64. PubMed ID: 9136942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunophenotypic characteristics of multiple myeloma cells].
    Li JL; Liu YR; Chang Y; Fu JY; Chen SS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Jun; 10(3):226-8. PubMed ID: 12513791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of beta 1 integrins (very late antigens-4 and -5) on myeloma cells and clinical correlates in patients with multiple myeloma.
    Nishinarita S; Shimada H; Ito T; Namiki H; Kawahira H; Sawada U; Horie T
    J Int Med Res; 1998; 26(1):37-42. PubMed ID: 9513075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood.
    Huang S; Law P; Young D; Ho AD
    Exp Hematol; 1998 Nov; 26(12):1162-71. PubMed ID: 9808056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of CD38/45 flow cytometry and immunofluorescence microscopy to detect blood plasma cells in patients with plasma cell proliferative disorders.
    Witzig TE; Meyers C; Therneau T; Greipp PR
    Leuk Lymphoma; 2000 Jul; 38(3-4):345-50. PubMed ID: 10830741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myeloma.
    Kimlinger T; Witzig TE
    Bone Marrow Transplant; 1997 Mar; 19(6):553-6. PubMed ID: 9085734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence of DNA aneuploidy in multiple myeloma does not correlate with stage of disease.
    Nowak R; Oelschlägel U; Range U; Mölle M; Ehninger G
    Am J Clin Pathol; 1998 Feb; 109(2):226-32. PubMed ID: 9583896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clonal hierachy in multiple myeloma.
    Rasmussen T; Jensen L; Johnsen HE
    Acta Oncol; 2000; 39(7):765-70. PubMed ID: 11145430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In multiple myeloma, clonotypic B lymphocytes are detectable among CD19+ peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain.
    Bergsagel PL; Smith AM; Szczepek A; Mant MJ; Belch AR; Pilarski LM
    Blood; 1995 Jan; 85(2):436-47. PubMed ID: 7529064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19).
    Van Camp B; Durie BG; Spier C; De Waele M; Van Riet I; Vela E; Frutiger Y; Richter L; Grogan TM
    Blood; 1990 Jul; 76(2):377-82. PubMed ID: 1695113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma cells composing plasmacytoma have phenotypes different from those of myeloma cells.
    Sakai A; Fujii T; Noda M; Hyodo H; Oda K; Kimura A
    Am J Hematol; 1996 Dec; 53(4):251-3. PubMed ID: 8948665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of adhesion molecules on myeloma cells.
    Tatsumi T; Shimazaki C; Goto H; Araki S; Sudo Y; Yamagata N; Ashihara E; Inaba T; Fujita N; Nakagawa M
    Jpn J Cancer Res; 1996 Aug; 87(8):837-42. PubMed ID: 8797890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometric detection of aneuploid CD38(++) plasmacells and CD19(+) B-lymphocytes in bone marrow, peripheral blood and PBSC harvest in multiple myeloma patients.
    Santonocito AM; Consoli U; Bagnato S; Milone G; Palumbo GA; Di Raimondo F; Stagno F; Guglielmo P; Giustolisi R
    Leuk Res; 2004 May; 28(5):469-77. PubMed ID: 15068900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lineage commitment of HLA-DR/CD38-defined progenitor cell subpopulations in bone marrow and mobilized peripheral blood assessed by four-color immunofluorescence.
    Harvey K; Higgins N; Akard L; Chang Q; Jansen J; Thompson J; Dugan M; Rizzo MT; English D
    J Hematother; 1997 Jun; 6(3):243-52. PubMed ID: 9234179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Myeloma precursor cells].
    Iwato K; Kawano MM
    Rinsho Ketsueki; 1993 Apr; 34(4):433-8. PubMed ID: 7685432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.